Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

97 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
An MDS xenograft model utilizing a patient-derived cell line.
Rhyasen GW, Wunderlich M, Tohyama K, Garcia-Manero G, Mulloy JC, Starczynowski DT. Rhyasen GW, et al. Among authors: starczynowski dt. Leukemia. 2014 May;28(5):1142-5. doi: 10.1038/leu.2013.372. Epub 2013 Dec 11. Leukemia. 2014. PMID: 24326684 Free PMC article. No abstract available.
Broad de-regulated U2AF1 splicing is prognostic and augments leukemic transformation via protein arginine methyltransferase activation.
Venkatasubramanian M, Schwartz L, Ramachandra N, Bennett J, Subramanian KR, Chen X, Gordon-Mitchell S, Fromowitz A, Pradhan K, Shechter D, Sahu S, Heiser D, Scherle P, Chetal K, Kulkarni A, Myers KC, Weirauch MT, Grimes HL, Starczynowski DT, Verma A, Salomonis N. Venkatasubramanian M, et al. Among authors: starczynowski dt. bioRxiv [Preprint]. 2024 Feb 8:2024.02.04.578798. doi: 10.1101/2024.02.04.578798. bioRxiv. 2024. PMID: 38370617 Free PMC article. Preprint.
High-resolution whole genome tiling path array CGH analysis of CD34+ cells from patients with low-risk myelodysplastic syndromes reveals cryptic copy number alterations and predicts overall and leukemia-free survival.
Starczynowski DT, Vercauteren S, Telenius A, Sung S, Tohyama K, Brooks-Wilson A, Spinelli JJ, Eaves CJ, Eaves AC, Horsman DE, Lam WL, Karsan A. Starczynowski DT, et al. Blood. 2008 Oct 15;112(8):3412-24. doi: 10.1182/blood-2007-11-122028. Epub 2008 Jul 28. Blood. 2008. PMID: 18663149 Free article.
Deregulation of microRNAs in myelodysplastic syndrome.
Rhyasen GW, Starczynowski DT. Rhyasen GW, et al. Among authors: starczynowski dt. Leukemia. 2012 Jan;26(1):13-22. doi: 10.1038/leu.2011.221. Epub 2011 Aug 19. Leukemia. 2012. PMID: 21852786 Review.
Implication of microRNAs in the pathogenesis of MDS.
Fang J, Varney M, Starczynowski DT. Fang J, et al. Among authors: starczynowski dt. Curr Pharm Des. 2012;18(22):3170-9. doi: 10.2174/1381612811209023170. Curr Pharm Des. 2012. PMID: 22571695 Free PMC article. Review.
Cytotoxic effects of bortezomib in myelodysplastic syndrome/acute myeloid leukemia depend on autophagy-mediated lysosomal degradation of TRAF6 and repression of PSMA1.
Fang J, Rhyasen G, Bolanos L, Rasch C, Varney M, Wunderlich M, Goyama S, Jansen G, Cloos J, Rigolino C, Cortelezzi A, Mulloy JC, Oliva EN, Cuzzola M, Starczynowski DT. Fang J, et al. Among authors: starczynowski dt. Blood. 2012 Jul 26;120(4):858-67. doi: 10.1182/blood-2012-02-407999. Epub 2012 Jun 8. Blood. 2012. PMID: 22685174 Free PMC article.
Targeting IRAK1 as a therapeutic approach for myelodysplastic syndrome.
Rhyasen GW, Bolanos L, Fang J, Jerez A, Wunderlich M, Rigolino C, Mathews L, Ferrer M, Southall N, Guha R, Keller J, Thomas C, Beverly LJ, Cortelezzi A, Oliva EN, Cuzzola M, Maciejewski JP, Mulloy JC, Starczynowski DT. Rhyasen GW, et al. Among authors: starczynowski dt. Cancer Cell. 2013 Jul 8;24(1):90-104. doi: 10.1016/j.ccr.2013.05.006. Cancer Cell. 2013. PMID: 23845443 Free PMC article.
Differential IRAK signaling in hematologic malignancies.
Rhyasen GW, Bolanos L, Starczynowski DT. Rhyasen GW, et al. Among authors: starczynowski dt. Exp Hematol. 2013 Dec;41(12):1005-7. doi: 10.1016/j.exphem.2013.09.008. Epub 2013 Sep 29. Exp Hematol. 2013. PMID: 24084080 Free PMC article. No abstract available.
IRAK1: oncotarget in MDS and AML.
Beverly LJ, Starczynowski DT. Beverly LJ, et al. Among authors: starczynowski dt. Oncotarget. 2014 Apr 15;5(7):1699-700. doi: 10.18632/oncotarget.1880. Oncotarget. 2014. PMID: 24880611 Free PMC article. No abstract available.
97 results